The COVID-19 pandemic has led to an unprecedented acceleration in many areas of scientific research and development. It has not only enabled an extraordinarily rapid vaccine rollout but has given health-care companies a chance to showcase the benefits of their groundbreaking work—from gene sequencing and DNA printing to big data solutions. How can we take advantage of this momentum and apply new scientific findings to push the boundaries of public health? Join our chairman Michael Milken and some of our most innovative healthcare leaders as they discuss the era of the genome and data-driven medicine and the opportunities it offers to improve the long-term quality of our lives.